Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke

PURPOSE OF REVIEW: To review the current evidence and ongoing clinical trials evaluating the efficacy and safety of tenecteplase (TNK), an alternative tissue plasminogen activator (tPA), in the acute management of arterial ischemic stroke (AIS). To date, alteplase is the only tPA approved by the Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhadid, Kenda, Oliveira, Lara, Etherton, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Cerebrovascular Disease and Stroke (S Silverman, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807245/
https://www.ncbi.nlm.nih.gov/pubmed/36618509
http://dx.doi.org/10.1007/s11936-022-00973-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807245/
https://www.ncbi.nlm.nih.gov/pubmed/36618509
http://dx.doi.org/10.1007/s11936-022-00973-2

Ejemplares similares